CD8A and central nervous system cancer: Injection of their isolated EV containing fraction into a subcutaneous glioma rat model led to an immune-mediated tumour reduction through apoptosis, an increase in tumour infiltrating CD4/CD8 lymphocytes, no change in blood/spleen lymphocytes and few other immune cell alterations.